[144] ResMed Inc. SEC Filing

Rhea-AI Filing Summary

ResMed Inc. (RMD) Form 144 reports a proposed sale of 8,009 common shares through Fidelity Brokerage Services with an aggregate market value of $2,227,590.84. The filing lists approximately 146,414,839 shares outstanding and an intended sale date of 09/08/2025 on the NYSE.

The shares were acquired under an option granted on 11/14/2018 and shown as acquired on 09/08/2025, with payment in cash. The filer previously sold 8,009 shares on 06/09/2025, 07/07/2025 and 08/07/2025 with gross proceeds of $2,011,909.65, $2,056,076.09 and $2,238,378.55, respectively.

Insights

Securities Analyst

TL;DR: Small scheduled insider sale disclosed; no material dilution indicated given company size.

The filing documents a single proposed sale of 8,009 shares valued at $2.23 million executed via Fidelity on 09/08/2025. Relative to the stated 146.4 million shares outstanding, the lot represents a de minimis percentage of the float. The shares derive from an option granted in 2018 and are to be paid in cash, consistent with routine exercised option dispositions. Multiple similar-sized sales in the prior three months are disclosed, indicating ongoing vesting/exercise and sell-through activity rather than a single large divestiture.

Corporate Governance Expert

TL;DR: Proper Rule 144 notice filed, showing compliance with insider-sale disclosure requirements.

The notice includes required acquisition details, broker information, and recent sale history, and contains the standard representation about material non-public information. The documented use of a brokerage firm and repeated monthly sales suggest routine monetization of vested holdings. The information provided is precise and meets disclosure expectations for insiders or related parties disposing of securities under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8009	2227590.84	146414839	09/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2025	Option Granted - 11/14/2018	Issuer			8009	09/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	06/09/2025	8009	2011909.65
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	07/07/2025	8009	2056076.09
Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123	Common	08/07/2025	8009	2238378.55

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for ResMed (RMD) disclose?

It discloses a proposed sale of 8,009 common shares via Fidelity on 09/08/2025 with an aggregate market value of $2,227,590.84.

How many shares outstanding does the filing report for RMD?

146,414,839 shares outstanding are reported in the Form 144 filing.

When were the shares to be sold acquired according to the filing?

The shares were acquired on 09/08/2025 under an option originally granted on 11/14/2018, with payment shown as cash.

Were there other recent sales by the same person?

Yes. Michael Farrell sold 8,009 shares on 06/09/2025, 8,009 shares on 07/07/2025 and 8,009 shares on 08/07/2025 with gross proceeds of $2,011,909.65, $2,056,076.09, and $2,238,378.55 respectively.

Which broker is handling the proposed sale?

Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI 02917) is listed as the broker for the transaction.